PositiveID Corp (PSID):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:PositiveID Corp (PSID) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7868
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products include firefly Dx systems, m-band, thermometer, and ENG mobile system. PositiveID’s technologies offer research and white papers, which include identification of zika virus on firefly Dx, PSID market opportunities, and ricin detection assay. The company’s technologies are used for airborne pathogen detection, rapid biological diagnostics and sample preparation applications. The company operates its offices in Delray Beach and Pleasanton, the US. PositiveID is headquartered in Delray Beach, Florida, the US.

PositiveID Corp (PSID) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
PositiveID Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
PositiveID Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
PositiveID Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
PositiveID Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
PositiveID Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
PositiveID Corp, Medical Equipment, Deal Details 11
Asset Purchase 11
ExcitePCR to Acquire FireflyDX Technology from PositiveID 11
Partnerships 12
PositiveID Enters Into Licensing Agreement With Smart Glucose Meter For iglucose Technology 12
PositiveID Enters into Co-Development Agreement with USSOCOM 13
Equity Offering 14
PositiveID Announces Private Placement Of Shares For US$5 Million 14
Debt Offering 15
PositiveID Completes First Tranche Of Private Placement Of Convertible Debentures For US$0.6 Million 15
Asset Transactions 16
ExcitePCR to Acquire FireflyDX Technology from PositiveID 16
PositiveID Completes Sale Of VeriChip And Health Link Businesses To VeriTeQ 17
Acquisition 19
PositiveID Acquires Thermomedics from Sanomedics 19
PositiveID Corporation Sells Stake In VeriTeQ For US$0.75 Million 20
PositiveID Corp – Key Competitors 21
PositiveID Corp – Key Employees 22
PositiveID Corp – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 25
Financial Announcements 25
Apr 03, 2018: PositiveID Reports 2017 Results; Fourth Quarter Revenues Increase 47% Year Over Year 25
Nov 14, 2017: PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year 27
Aug 15, 2017: PositiveID Reports Second Quarter 2017 Results 29
May 16, 2017: PositiveID Reports First Quarter 2017 Results 30
May 01, 2017: PositiveID Announces Highlights for First Quarter 2017 31
Apr 03, 2017: PositiveID Reports 2016 Results; Revenue of $5.6 Million, up 89% Year over Year 32
Corporate Communications 33
Sep 26, 2017: PositiveID Subsidiary ExcitePCR Announces Board of Advisors 33
Aug 24, 2017: PositiveID’s Subsidiary, ExcitePCR, Hires Thirty-Year Marketing Veteran, David L. Politis, as its Chief Marketing & Sales Officer 34
May 30, 2017: PositiveID Subsidiary ExcitePCR Names Chief Science Officer 35
Product News 36
Nov 27, 2017: PositiveID to Present at the LD MICRO “Main Event” Investor Conference 36
Sep 18, 2017: PositiveID’s ExcitePCR Subsidiary CEO to Speak on National Academies of Science, Engineering, and Medicine Panel Today 37
Apr 24, 2017: PositiveID Updates Report for its Molecular Diagnostics, Mobile Labs and Medical Device Businesses with Addressable Markets Exceeding $30 Billion 38
Jan 25, 2017: PositiveID to Present at RedChip’s Global Online Growth Conference 39
Other Significant Developments 40
Jan 17, 2018: PositiveID’s E-N-G Mobile Systems 2017 Bookings Increase 100% Year Over Year 40
Jan 10, 2018: PositiveID Announces 2017 Highlights and Projects Continued 30% Growth 41
Nov 28, 2017: PositiveID Projects Revenue Growth of More Than 30% Year-over-Year through First Quarter of 2018 42
Oct 09, 2017: PositiveID Announces Highlights for the Third Quarter of 2017 43
Jun 28, 2017: PositiveID Announces Highlights for the First Half of 2017 44
Mar 14, 2017: PositiveID’s E-N-G Mobile Systems’ 2017 Bookings Through February Total $1.7 Million, Up More than 200% from Prior Quarter 45
Feb 21, 2017: PositiveID Announces 2016 Highlights 46
Appendix 47
Methodology 47
About GlobalData 47
Contact Us 47
Disclaimer 47

List of Tables
PositiveID Corp, Medical Equipment, Key Facts, 2017 2
PositiveID Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
PositiveID Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
PositiveID Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
PositiveID Corp, Deals By Market, 2012 to YTD 2018 9
PositiveID Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
ExcitePCR to Acquire FireflyDX Technology from PositiveID 11
PositiveID Enters Into Licensing Agreement With Smart Glucose Meter For iglucose Technology 12
PositiveID Enters into Co-Development Agreement with USSOCOM 13
PositiveID Announces Private Placement Of Shares For US$5 Million 14
PositiveID Completes First Tranche Of Private Placement Of Convertible Debentures For US$0.6 Million 15
ExcitePCR to Acquire FireflyDX Technology from PositiveID 16
PositiveID Completes Sale Of VeriChip And Health Link Businesses To VeriTeQ 17
PositiveID Acquires Thermomedics from Sanomedics 19
PositiveID Corporation Sells Stake In VeriTeQ For US$0.75 Million 20
PositiveID Corp, Key Competitors 21
PositiveID Corp, Key Employees 22
PositiveID Corp, Other Locations 23
PositiveID Corp, Subsidiaries 23

List of Figures
PositiveID Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
PositiveID Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
PositiveID Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
PositiveID Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
PositiveID Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[PositiveID Corp (PSID):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Symbiotec Pharmalab Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Symbiotec Pharmalab Ltd (Symbiotec) is a medical laboratory that manufactures active pharmaceutical ingredients. The laboratory develops, produces and markets research-based cortico steroids and steroid-hormone APIs. Its cortico-steroids APIs include clobetasol propionate, betamethasone dipr …
  • MRI Interventions Inc (MRIC)-医療機器分野:企業M&A・提携分析
    Summary MRI Interventions Inc (MRI Interventions) is a medical device company that develops and commercializes platforms for performing invasive surgical procedures. The company’s product platforms include clearpoint system, which is used for minimally invasive surgical procedures in the brain; and …
  • Genfit SA (GNFT):企業の財務・戦略的SWOT分析
    Summary Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, NASH, TGFTX1 and Nitazoxanide (NTZ). Its TGFTX1 is a research p …
  • Chiltern International Inc-製薬・医療分野:企業M&A・提携分析
    Summary Chiltern International Inc (Chiltern) is a contract research organization that provides clinical trial development services. It conducts clinical trials for medical devices, drugs, and diagnostics across all stages of development. The company offer wide range of services including clinical d …
  • WestWind Energy Pty Ltd:電力:M&Aディール及び事業提携情報
    Summary WestWind Energy Pty Ltd (West Wind) is a renewable energy company that offers development, construction, operation and management of wind farms and other energy projects. The company provides energy consultation, planning, and maintenance services. It also operates and maintains wind turbine …
  • VGP N.V.:企業の戦略・SWOT・財務情報
    VGP N.V. - Strategy, SWOT and Corporate Finance Report Summary VGP N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Encore Dermatology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Encore Dermatology Inc (Encore Dermatology) is a specialty dermatology company, which develops and commercializes novel prescription medicines and medical devices for the treatment of topical dermatological disorders. The company’s products include HylatopicPlus lotion, a combination of vari …
  • Reliance Worldwide Corporation Ltd (RWC):企業の財務・戦略的SWOT分析
    Reliance Worldwide Corporation Ltd (RWC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Dino Polska S.A (DNP):企業の財務・戦略的SWOT分析
    Dino Polska S.A (DNP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Hunan Corun New Energy Co Ltd (600478):電力:M&Aディール及び事業提携情報
    Summary Hunan Corun New Energy Co Ltd (Corun) is a battery manufacturing company that designs, research's, produces and commercializes materials and batteries. The company develops high quality energy materials, extension products and advanced batteries, among others. It also manufactures ultra-inte …
  • Synexus Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務分析
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • DBS Bank Ltd:企業のM&A・事業提携・投資動向
    DBS Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DBS Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • TOR Minerals International Inc (TORM):企業の財務・戦略的SWOT分析
    Summary TOR Minerals International Inc (TOR) is a chemical company that manufactures and distributes mineral and pigment products. The company provides products such as optiload, aluprem, haltex, and others. It also offers alumina trihydrate and boehmite halogen-free flame retardant and smoke suppre …
  • 1-800 Contacts Inc:医療機器:M&Aディール及び事業提携情報
    Summary 1-800 Contacts Inc (1-800 Contacts) is a medical device company that markets contact lenses. The company provides various contact lens types such as vial contact lenses, disposable contact lenses, multifocal or bifocal lenses, toric or astigmatism lenses, color and enhancing lenses, and othe …
  • Genomic Expression Inc:企業の製品パイプライン分析
    Summary Genomic Expression Inc (Genomic Expression) is a provider of cancer diagnostics services that offers treatments for cancer diagnostics for personalized medicine. The company offers products such as sample sequencing sample preparation kit and analytical platform. Its sequencing platform prov …
  • Miragen Therapeutics Inc (MGEN):医療機器:M&Aディール及び事業提携情報
    Summary Miragen Therapeutics, Inc. (Miragen) is a clinical stage biopharmaceutical company. It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases. The company is developing its pipeline products for the treatment of Cutaneous T-Cell Lymphoma (CTCL), …
  • Aptevo Therapeutics Inc (APVO):企業の財務・戦略的SWOT分析
    Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Rockwell Medical Inc (RMTI):医療機器:M&Aディール及び事業提携情報
    Summary Rockwell Medical Inc (Rockwell) is a biopharmaceutical company that focuses on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company’s major products include Triferic, an iron d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆